The DOI matches its Crossref record; 153 of the 153 references it cites were found in a registry or an index.
In silico methods for drug repurposing and pharmacology
Open accessAbstract
Data in the biological, chemical, and clinical domains are accumulating at ever‐increasing rates and have the potential to accelerate and inform drug development in new ways. Challenges and opportunities now lie in developing analytic tools to transform these often complex and heterogeneous data into testable hypotheses and actionable insights. This is the aim of computational pharmacology, which uses in silico techniques to better understand and predict how drugs affect biological systems, which can in turn improve clinical use, avoid unwanted side effects, and guide selection and development of better treatments. One exciting application of computational pharmacology is drug repurposing—finding new uses for existing drugs. Already yielding many promising candidates, this strategy has the potential to improve the efficiency of the drug development process and reach patient populations with previously unmet needs such as those with rare diseases. While current techniques in computational pharmacology and drug repurposing often focus on just a single data modality such as gene expression or drug–target interactions, we argue that methods such as matrix factorization that can integrate data within and across diverse data types have the potential to improve predictive performance and provide a fuller picture of a drug's pharmacological action. WIREs Syst Biol Med 2016, 8:186–210. doi: 10.1002/wsbm.1337 This article is categorized under: Analytical and Computational Methods > Computational Methods Translational, Genomic, and Systems Medicine > Translational Medicine
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
WGCNA: an R package for weighted correlation network analysis
Langfelder, P., & Horvath, S. (2008) · BMC Bioinformatics · doi:10.1186/1471-2105-9-559 · Cited by 27,252
Gene Expression Omnibus: NCBI gene expression and hybridization array data repository
Edgar, R. (2002) · Nucleic Acids Research · doi:10.1093/nar/30.1.207 · Cited by 13,288
Yung-Chi, C., & Prusoff, W. H. (1973) · Biochemical Pharmacology · doi:10.1016/0006-2952(73)90196-2 · Cited by 12,922
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
Barretina, J., Caponigro, G., Stransky, N., Venkatesan, K., Margolin, A. A., Kim, S., Wilson, C. J., Lehár, J., Kryukov, G. V., Sonkin, D., et al. (2012) · Nature · doi:10.1038/nature11003 · Cited by 7,950
Weininger, D. (1988) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci00057a005 · Cited by 7,436
A General Framework for Weighted Gene Co-Expression Network Analysis
Zhang, B., & Horvath, S. (2005) · Statistical Applications in Genetics and Molecular Biology · doi:10.2202/1544-6115.1128 · Cited by 5,684
Lamb, J., Crawford, E. D., Peck, D., Modell, J. W., Blat, I. C., Wrobel, M. J., Lerner, J., Brunet, J.-P., Subramanian, A., Ross, K. N., et al. (2006) · Science · doi:10.1126/science.1132939 · Cited by 5,257
Host–microbe interactions have shaped the genetic architecture of inflammatory bowel disease
The International IBD Genetics Consortium (IIBDGC), Jostins, L., Ripke, S., Weersma, R. K., Duerr, R. H., McGovern, D. P., Hui, K. Y., Lee, J. C., Philip Schumm, L., Sharma, Y., et al. (2012) · Nature · doi:10.1038/nature11582 · Cited by 4,722
Network pharmacology: the next paradigm in drug discovery
Hopkins, A. L. (2008) · Nature Chemical Biology · doi:10.1038/nchembio.118 · Cited by 4,622
The unified medical language system (UMLS): integrating biomedical terminology
Bodenreider, O. (2004) · Nucleic Acids Research · doi:10.1093/nar/gkh061 · Cited by 4,356
Can the pharmaceutical industry reduce attrition rates?
Kola, I., & Landis, J. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1470 · Cited by 4,167
Yang, W., Soares, J., Greninger, P., Edelman, E. J., Lightfoot, H., Forbes, S., Bindal, N., Beare, D., Smith, J. A., Thompson, I. R., et al. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks1111 · Cited by 4,051
DrugBank: a comprehensive resource for in silico drug discovery and exploration
Wishart, D. S. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkj067 · Cited by 3,892
Molecular Docking: A Powerful Approach for Structure-Based Drug Discovery
Meng, X.-Y., Zhang, H.-X., Mezei, M., & Cui, M. (2011) · Current Computer Aided-Drug Design · doi:10.2174/157340911795677602 · Cited by 3,771
How to improve R&D productivity: the pharmaceutical industry's grand challenge
Paul, S. M., Mytelka, D. S., Dunwiddie, C. T., Persinger, C. C., Munos, B. H., Lindborg, S. R., & Schacht, A. L. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3078 · Cited by 3,566
Drug repositioning: identifying and developing new uses for existing drugs
Ashburn, T. T., & Thor, K. B. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1468 · Cited by 3,237
Effects of torcetrapib in patients at high risk for coronary events
Barter, P. J., Caulfield, M., Eriksson, M., Grundy, S. M., Kastelein, J. J. P., Komajda, M., Lopez-Sendon, J., Mosca, L., Tardif, J.-C., Waters, D. D., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa0706628 · Cited by 3,139
From genomics to chemical genomics: new developments in KEGG
Kanehisa, M. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkj102 · Cited by 3,120
The NCI60 human tumour cell line anticancer drug screen
Shoemaker, R. H. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1951 · Cited by 2,620
Relating protein pharmacology by ligand chemistry
Keiser, M. J., Roth, B. L., Armbruster, B. N., Ernsberger, P., Irwin, J. J., & Shoichet, B. K. (2007) · Nature Biotechnology · doi:10.1038/nbt1284 · Cited by 2,402
BindingDB: a web-accessible database of experimentally determined protein-ligand binding affinities
Liu, T., Lin, Y., Wen, X., Jorissen, R. N., & Gilson, M. K. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkl999 · Cited by 2,124
Scale-Free Networks: A Decade and Beyond
Barabási, A.-L. (2009) · Science · doi:10.1126/science.1173299 · Cited by 2,109
Reoptimization of MDL Keys for Use in Drug Discovery
Durant, J. L., Leland, B. A., Henry, D. R., & Nourse, J. G. (2002) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci010132r · Cited by 1,862
Pharmacogenomics Knowledge for Personalized Medicine
Whirl-Carrillo, M., McDonagh, E. M., Hebert, J. M., Gong, L., Sangkuhl, K., Thorn, C. F., Altman, R. B., & Klein, T. E. (2012) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2012.96 · Cited by 1,796
Predicting new molecular targets for known drugs
Keiser, M. J., Setola, V., Irwin, J. J., Laggner, C., Abbas, A. I., Hufeisen, S. J., Jensen, N. H., Kuijer, M. B., Matos, R. C., Tran, T. B., et al. (2009) · Nature · doi:10.1038/nature08506 · Cited by 1,667
Integrated Systems Approach Identifies Genetic Nodes and Networks in Late-Onset Alzheimer’s Disease
Zhang, B., Gaiteri, C., Bodea, L.-G., Wang, Z., McElwee, J., Podtelezhnikov, A. A., Zhang, C., Xie, T., Tran, L., Dobrin, R., et al. (2013) · Cell · doi:10.1016/j.cell.2013.03.030 · Cited by 1,657
The ChEMBL bioactivity database: an update
Bento, A. P., Gaulton, A., Hersey, A., Bellis, L. J., Chambers, J., Davies, M., Krüger, F. A., Light, Y., Mak, L., McGlinchey, S., et al. (2014) · Nucleic Acids Research · doi:10.1093/nar/gkt1031 · Cited by 1,492
Genetics of gene expression and its effect on disease
Emilsson, V., Thorleifsson, G., Zhang, B., Leonardson, A. S., Zink, F., Zhu, J., Carlson, S., Helgason, A., Walters, G. B., Gunnarsdottir, S., et al. (2008) · Nature · doi:10.1038/nature06758 · Cited by 1,296
PubChem: Integrated Platform of Small Molecules and Biological Activities
(2008) · Annual Reports in Computational Chemistry · doi:10.1016/s1574-1400(08)00012-1 · Cited by 1,263
Drug target identification using side-effect similarity
Campillos, M., Kuhn, M., Gavin, A.-C., Jensen, L. J., & Bork, P. (2008) · Science · doi:10.1126/science.1158140 · Cited by 1,248
ChEBI: a database and ontology for chemical entities of biological interest
Degtyarenko, K., de Matos, P., Ennis, M., Hastings, J., Zbinden, M., McNaught, A., Alcantara, R., Darsow, M., Guedj, M., & Ashburner, M. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm791 · Cited by 1,126
The Effect of Finasteride in Men with Benign Prostatic Hyperplasia
Gormley, G. J., Stoner, E., Bruskewitz, R. C., Imperato-McGinley, J., Walsh, P. C., McConnell, J. D., Andriole, G. L., Geller, J., Bracken, B. R., Tenover, J. S., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199210223271701 · Cited by 1,124
An integrative genomics approach to infer causal associations between gene expression and disease
Schadt, E. E., Lamb, J., Yang, X., Zhu, J., Edwards, S., GuhaThakurta, D., Sieberts, S. K., Monks, S., Reitman, M., Zhang, C., et al. (2005) · Nature Genetics · doi:10.1038/ng1589 · Cited by 1,043
Lost in translation: animal models and clinical trials in cancer treatment.
(2014) · Europe PMC (PubMed Central) · Cited by 1,033
Data-driven prediction of drug effects and interactions
Tatonetti, N. P., Ye, P. P., Daneshjou, R., & Altman, R. B. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003377 · Cited by 936
Disease Ontology: a backbone for disease semantic integration
Schriml, L. M., Arze, C., Nadendla, S., Chang, Y.-W. W., Mazaitis, M., Felix, V., Feng, G., & Kibbe, W. A. (2012) · Nucleic Acids Research · doi:10.1093/nar/gkr972 · Cited by 929
The productivity crisis in pharmaceutical R&D
Pammolli, F., Magazzini, L., & Riccaboni, M. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3405 · Cited by 918
Pharmacophore modeling and applications in drug discovery: challenges and recent advances
Yang, S.-Y. (2010) · Drug Discovery Today · doi:10.1016/j.drudis.2010.03.013 · Cited by 901
A side effect resource to capture phenotypic effects of drugs
Kuhn, M., Campillos, M., Letunic, I., Jensen, L. J., & Bork, P. (2010) · Molecular Systems Biology · doi:10.1038/msb.2009.98 · Cited by 899
Large-scale prediction and testing of drug activity on side-effect targets
Lounkine, E., Keiser, M. J., Whitebread, S., Mikhailov, D., Hamon, J., Jenkins, J. L., Lavan, P., Weber, E., Doak, A. K., Côté, S., et al. (2012) · Nature · doi:10.1038/nature11159 · Cited by 881
PREDICT: a method for inferring novel drug indications with application to personalized medicine
Gottlieb, A., Stein, G. Y., Ruppin, E., & Sharan, R. (2011) · Molecular Systems Biology · doi:10.1038/msb.2011.26 · Cited by 881
InChI, the IUPAC International Chemical Identifier
Heller, S. R., McNaught, A., Pletnev, I., Stein, S., & Tchekhovskoi, D. (2015) · Journal of Cheminformatics · doi:10.1186/s13321-015-0068-4 · Cited by 867
Basu, A., Bodycombe, N. E., Cheah, J. H., Price, E. V., Liu, K., Schaefer, G. I., Ebright, R. Y., Stewart, M. L., Ito, D., Wang, S., et al. (2013) · Cell · doi:10.1016/j.cell.2013.08.003 · Cited by 833
Prediction of Drug-Target Interactions and Drug Repositioning via Network-Based Inference
Cheng, F., Liu, C., Jiang, J., Lu, W., Li, W., Liu, G., Zhou, W., Huang, J., & Tang, Y. (2012) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1002503 · Cited by 818
Discovery of drug mode of action and drug repositioning from transcriptional responses
Iorio, F., Bosotti, R., Scacheri, E., Belcastro, V., Mithbaokar, P., Ferriero, R., Murino, L., Tagliaferri, R., Brunetti-Pierri, N., Isacchi, A., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1000138107 · Cited by 816
Global mapping of pharmacological space
Paolini, G. V., Shapland, R. H. B., van Hoorn, W. P., Mason, J. S., & Hopkins, A. L. (2006) · Nature Biotechnology · doi:10.1038/nbt1228 · Cited by 811
Sirota, M., Dudley, J. T., Kim, J., Chiang, A. P., Morgan, A. A., Sweet-Cordero, A., Sage, J., & Butte, A. J. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3001318 · Cited by 799
Self-citationMedical Subject Headings (MeSH).
(2000) · Europe PMC (PubMed Central) · Cited by 789
Zebrafish Behavioral Profiling Links Drugs to Biological Targets and Rest/Wake Regulation
Rihel, J., Prober, D. A., Arvanites, A., Lam, K., Zimmerman, S., Jang, S., Haggarty, S. J., Kokel, D., Rubin, L. L., Peterson, R. T., et al. (2010) · Science · doi:10.1126/science.1183090 · Cited by 778
A community effort to assess and improve drug sensitivity prediction algorithms
Community, N. D., Costello, J. C., Heiser, L. M., Georgii, E., Gönen, M., Menden, M. P., Wang, N. J., Bansal, M., Ammad-ud-din, M., Hintsanen, P., et al. (2014) · Nature Biotechnology · doi:10.1038/nbt.2877 · Cited by 772
On Outliers and Activity CliffsWhy QSAR Often Disappoints
Maggiora, G. M. (2006) · Journal of Chemical Information and Modeling · doi:10.1021/ci060117s · Cited by 728
Phase II and Phase III attrition rates 2011–2012
Arrowsmith, J., & Miller, P. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd4090 · Cited by 697
Wang, Y., Xiao, J., Suzek, T. O., Zhang, J., Wang, J., Zhou, Z., Han, L., Karapetyan, K., Dracheva, S., Shoemaker, B. A., et al. (2012) · Nucleic Acids Research · doi:10.1093/nar/gkr1132 · Cited by 659
Supervised prediction of drug–target interactions using bipartite local models
Bleakley, K., & Yamanishi, Y. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp433 · Cited by 628
Computational Repositioning of the Anticonvulsant Topiramate for Inflammatory Bowel Disease
Dudley, J. T., Sirota, M., Shenoy, M., Pai, R. K., Roedder, S., Chiang, A. P., Morgan, A. A., Sarwal, M. M., Pasricha, P. J., & Butte, A. J. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3002648 · Cited by 605
Self-citationAmini, A., & Cheng, C. (2013) · Scientific Reports · doi:10.1038/srep03316 · Cited by 594
Structure-Based Virtual Screening for Drug Discovery: a Problem-Centric Review
Cheng, T., Li, Q., Zhou, Z., Wang, Y., & Bryant, S. H. (2012) · The AAPS Journal · doi:10.1208/s12248-012-9322-0 · Cited by 574
Identification of type 2 diabetes subgroups through topological analysis of patient similarity
Li, L., Cheng, W.-Y., Glicksberg, B. S., Gottesman, O., Tamler, R., Chen, R., Bottinger, E. P., & Dudley, J. T. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aaa9364 · Cited by 549
Self-citationExploiting drug-disease relationships for computational drug repositioning
Dudley, J. T., Deshpande, T., & Butte, A. J. (2011) · Briefings in Bioinformatics · doi:10.1093/bib/bbr013 · Cited by 524
Self-citationEffectiveness of smoking cessation therapies: a systematic review and meta-analysis
Wu, P., Wilson, K., Dimoulas, P., & Mills, E. J. (2006) · BMC Public Health · doi:10.1186/1471-2458-6-300 · Cited by 484
Similarity-based machine learning methods for predicting drug–target interactions: a brief review
Ding, H., Takigawa, I., Mamitsuka, H., & Zhu, S. (2014) · Briefings in Bioinformatics · doi:10.1093/bib/bbt056 · Cited by 427
Phenotypic screens as a renewed approach for drug discovery
Zheng, W., Thorne, N., & McKew, J. C. (2013) · Drug Discovery Today · doi:10.1016/j.drudis.2013.07.001 · Cited by 423
Deconstructing the Drug Development Process: The New Face of Innovation
Kaitin, K. I. (2010) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2009.293 · Cited by 418
Phenotypic vs. Target-Based Drug Discovery for First-in-Class Medicines
Swinney, D. C. (2013) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2012.236 · Cited by 413
Jucker, M. (2010) · Nature Medicine · doi:10.1038/nm.2224 · Cited by 401
Huang, R., Southall, N., Wang, Y., Yasgar, A., Shinn, P., Jadhav, A., Nguyen, D.-T., & Austin, C. P. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3001862 · Cited by 401
Drug repurposing and human parasitic protozoan diseases
Andrews, K. T., Fisher, G., & Skinner-Adams, T. S. (2014) · International Journal for Parasitology: Drugs and Drug Resistance · doi:10.1016/j.ijpddr.2014.02.002 · Cited by 383
Protein-ligand interaction prediction: an improved chemogenomics approach
Jacob, L., & Vert, J.-P. (2008) · Bioinformatics · doi:10.1093/bioinformatics/btn409 · Cited by 378
O’Boyle, N. M. (2012) · Journal of Cheminformatics · doi:10.1186/1758-2946-4-22 · Cited by 362
Improving compound–protein interaction prediction by building up highly credible negative samples
Liu, H., Sun, J., Guan, J., Zheng, J., & Zhou, S. (2015) · Bioinformatics · doi:10.1093/bioinformatics/btv256 · Cited by 359
Drug repositioning: a machine-learning approach through data integration
Napolitano, F., Zhao, Y., Moreira, V. M., Tagliaferri, R., Kere, J., D’Amato, M., & Greco, D. (2013) · Journal of Cheminformatics · doi:10.1186/1758-2946-5-30 · Cited by 349
Nidhi, Glick, M., Davies, J. W., & Jenkins, J. L. (2006) · Journal of Chemical Information and Modeling · doi:10.1021/ci060003g · Cited by 340
Bender, A., Scheiber, J., Glick, M., Davies, J. W., Azzaoui, K., Hamon, J., Urban, L., Whitebread, S., & Jenkins, J. L. (2007) · ChemMedChem · doi:10.1002/cmdc.200700026 · Cited by 327
Learning Bayesian networks: approaches and issues
Daly, R., Shen, Q., & Aitken, S. (2011) · The Knowledge Engineering Review · doi:10.1017/s0269888910000251 · Cited by 319
Duan, Q., Flynn, C., Niepel, M., Hafner, M., Muhlich, J. L., Fernandez, N. F., Rouillard, A. D., Tan, C. M., Chen, E. Y., Golub, T. R., et al. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku476 · Cited by 314
Human Disease-Drug Network Based on Genomic Expression Profiles
Hu, G., & Agarwal, P. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006536 · Cited by 310
An overview of the PubChem BioAssay resource
Wang, Y., Bolton, E., Dracheva, S., Karapetyan, K., Shoemaker, B. A., Suzek, T. O., Wang, J., Xiao, J., Zhang, J., & Bryant, S. H. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkp965 · Cited by 295
A network view of disease and compound screening
Schadt, E. E., Friend, S. H., & Shaywitz, D. A. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2826 · Cited by 291
Gaiteri, C., Ding, Y., French, B., Tseng, G. C., & Sibille, E. (2014) · Genes, Brain and Behavior · doi:10.1111/gbb.12106 · Cited by 289
In silico repositioning of approved drugs for rare and neglected diseases
Ekins, S., Williams, A. J., Krasowski, M. D., & Freundlich, J. S. (2011) · Drug Discovery Today · doi:10.1016/j.drudis.2011.02.016 · Cited by 288
Similarity-based modeling in large-scale prediction of drug-drug interactions
Vilar, S., Uriarte, E., Santana, L., Lorberbaum, T., Hripcsak, G., Friedman, C., & Tatonetti, N. P. (2014) · Nature Protocols · doi:10.1038/nprot.2014.151 · Cited by 280
Margolis, R., Derr, L., Dunn, M., Huerta, M., Larkin, J., Sheehan, J., Guyer, M., & Green, E. D. (2014) · Journal of the American Medical Informatics Association · doi:10.1136/amiajnl-2014-002974 · Cited by 276
RxNorm: prescription for electronic drug information exchange
Liu, S., Ma, W., Moore, R., Ganesan, V., & Nelson, S. (2005) · IT Professional · doi:10.1109/mitp.2005.122 · Cited by 274
Systematic Evaluation of Drug–Disease Relationships to Identify Leads for Novel Drug Uses
Chiang, A. P., & Butte, A. J. (2009) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2009.103 · Cited by 268
Systematic Drug Repositioning Based on Clinical Side-Effects
Yang, L., & Agarwal, P. (2011) · PLoS ONE · doi:10.1371/journal.pone.0028025 · Cited by 266
Transcriptional data: a new gateway to drug repositioning?
Iorio, F., Rittman, T., Ge, H., Menden, M., & Saez-Rodriguez, J. (2013) · Drug Discovery Today · doi:10.1016/j.drudis.2012.07.014 · Cited by 237
Virtual Screening in Drug Discovery
(2005) · CRC Press eBooks · doi:10.1201/9781420028775 · Cited by 235
Drug repositioning for orphan diseases
Sardana, D., Zhu, C., Zhang, M., Gudivada, R. C., Yang, L., & Jegga, A. G. (2011) · Briefings in Bioinformatics · doi:10.1093/bib/bbr021 · Cited by 228
Xu, H., Aldrich, M. C., Chen, Q., Liu, H., Peterson, N. B., Dai, Q., Levy, M., Shah, A., Han, X., Ruan, X., et al. (2015) · Journal of the American Medical Informatics Association · doi:10.1136/amiajnl-2014-002649 · Cited by 218
DrugNet: Network-based drug–disease prioritization by integrating heterogeneous data
Martínez, V., Navarro, C., Cano, C., Fajardo, W., & Blanco, A. (2015) · Artificial Intelligence in Medicine · doi:10.1016/j.artmed.2014.11.003 · Cited by 214
Ferry, L., & Johnston, J. (2003) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2003.tb10468.x · Cited by 209
Chang, R. L., Xie, L., Xie, L., Bourne, P. E., & Palsson, B. Ø. (2010) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1000938 · Cited by 204
Web-scale pharmacovigilance: listening to signals from the crowd
White, R. W., Tatonetti, N. P., Shah, N. H., Altman, R. B., & Horvitz, E. (2013) · Journal of the American Medical Informatics Association · doi:10.1136/amiajnl-2012-001482 · Cited by 199
The BellKor 2008 Solution to the Netflix Prize
Bell, R. M., Koren, Y., & Volinsky, C. T. (2007) · Cited by 188
Predicting Drug–Target Interactions Using Probabilistic Matrix Factorization
Cobanoglu, M. C., Liu, C., Hu, F., Oltvai, Z. N., & Bahar, I. (2013) · Journal of Chemical Information and Modeling · doi:10.1021/ci400219z · Cited by 187
Modeling Promiscuity Based on in vitro Safety Pharmacology Profiling Data
Azzaoui, K., Hamon, J., Faller, B., Whitebread, S., Jacoby, E., Bender, A., Jenkins, J. L., & Urban, L. (2007) · ChemMedChem · doi:10.1002/cmdc.200700036 · Cited by 176
Mapping Adverse Drug Reactions in Chemical Space
Scheiber, J., Jenkins, J. L., Sukuru, S. C. K., Bender, A., Mikhailov, D., Milik, M., Azzaoui, K., Whitebread, S., Hamon, J., Urban, L., et al. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm801546k · Cited by 160
A Comprehensive Survey of Small-Molecule Binding Pockets in Proteins
Gao, M., & Skolnick, J. (2013) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1003302 · Cited by 154
Limestone: High-throughput candidate phenotype generation via tensor factorization
Ho, J. C., Ghosh, J., Steinhubl, S. R., Stewart, W. F., Denny, J. C., Malin, B., & Sun, J. (2014) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2014.07.001 · Cited by 149
Comprehensive prediction of drug-protein interactions and side effects for the human proteome
Zhou, H., Gao, M., & Skolnick, J. (2015) · Scientific Reports · doi:10.1038/srep11090 · Cited by 138
Causal reasoning on biological networks: interpreting transcriptional changes
Chindelevitch, L., Ziemek, D., EnayetAllah, A. E., Randhawa, R., Sidders, B. S., Brockel, C., & Huang, E. S. (2012) · Bioinformatics · doi:10.1093/bioinformatics/bts090 · Cited by 136
Systematic evaluation of connectivity map for disease indications
Cheng, J., Yang, L., Kumar, V. D., & Agarwal, P. (2014) · Genome Medicine · doi:10.1186/s13073-014-0095-1 · Cited by 131
Construction of Drug Network Based on Side Effects and Its Application for Drug Repositioning
Ye, H., Liu, Q., & Jia, W. P. (2014) · PLoS ONE · doi:10.1371/journal.pone.0087864 · Cited by 130
Krüger, D. M., & Evers, A. (2009) · ChemMedChem · doi:10.1002/cmdc.200900314 · Cited by 125
Iskar, M., Zeller, G., Blattmann, P., Campillos, M., Kuhn, M., Kaminska, K. H., Runz, H., Gavin, A., Pepperkok, R., van Noort, V., et al. (2013) · Molecular Systems Biology · doi:10.1038/msb.2013.20 · Cited by 118
Chen, Z., Li, H., Zhang, Q., Bao, X.-G., Yu, K., Luo, X., Zhu, W., & Jiang, H. (2009) · Acta Pharmacologica Sinica · doi:10.1038/aps.2009.159 · Cited by 117
Inference of Gene Regulatory Networks Using Time-Series Data: A Survey
Sima, C., Hua, J., & Jung, S. (2009) · Current Genomics · doi:10.2174/138920209789177610 · Cited by 111
Discovering disease-disease associations by fusing systems-level molecular data
Žitnik, M., Janjić, V., Larminie, C., Zupan, B., & Pržulj, N. (2013) · Scientific Reports · doi:10.1038/srep03202 · Cited by 106
Yom‐Tov, E., & Gabrilovich, E. (2013) · Journal of Medical Internet Research · doi:10.2196/jmir.2614 · Cited by 101
Virtual Screen for Ligands of Orphan G Protein-Coupled Receptors
Bock, J. R., & Gough, D. A. (2005) · Journal of Chemical Information and Modeling · doi:10.1021/ci050006d · Cited by 100
Food for thought... on the economics of animal testing
Bottini, A. (2009) · ALTEX · doi:10.14573/altex.2009.1.3 · Cited by 93
Pparγ2 Is a Key Driver of Longevity in the Mouse
Argmann, C., Dobrin, R., Heikkinen, S., Auburtin, A., Pouilly, L., Cock, T., Koutníková, H., Zhu, J., Schadt, E. E., & Auwerx, J. H. (2009) · PLoS Genetics · doi:10.1371/journal.pgen.1000752 · Cited by 88
Matrix Factorization-Based Prediction of Novel Drug Indications by Integrating Genomic Space
Dai, W., Liu, X., Gao, Y., Chen, L., Song, J., Chen, D., Gao, K., Jiang, Y., Yang, Y., Chen, M., et al. (2015) · Computational and Mathematical Methods in Medicine · doi:10.1155/2015/275045 · Cited by 79
Realism in drug discovery—could Cassandra be right?
Horrobin, D. F. (2001) · Nature Biotechnology · doi:10.1038/nbt1201-1099 · Cited by 79
Zhang, P., Wang, F., & Hu, J. (2014) · PubMed · Cited by 75
Community-driven development for computational biology at Sprints, Hackathons and Codefests
Möller, S., Afgan, E., Banck, M., Bonnal, R. J. P., Booth, T., Chilton, J. M., Cock, P., Gumbel, M., Harris, N. L., Holland, R., et al. (2014) · BMC Bioinformatics · doi:10.1186/1471-2105-15-s14-s7 · Cited by 72
Data Analysis and Data Mining: Current Issues in Biomedical Informatics
Diomidous, M., Sarkar, I. N., Takabayashi, K., Ziegler, A., McCray, A. T., & Bellazzi, R. (2011) · Methods of Information in Medicine · doi:10.3414/me11-06-0002 · Cited by 70
FINDSITE comb : A Threading/Structure-Based, Proteomic-Scale Virtual Ligand Screening Approach
Zhou, H., & Skolnick, J. (2012) · Journal of Chemical Information and Modeling · doi:10.1021/ci300510n · Cited by 64
Huang, Y., Yeh, H., & Soo, V. (2013) · BMC Medical Genomics · doi:10.1186/1755-8794-6-s3-s4 · Cited by 63
Genotype imputation via matrix completionPreprint
Chi, E. C., Zhou, H., Chen, G. K., Vecchyo, D. O., & Lange, K. L. (2012) · Genome Research · doi:10.1101/gr.145821.112 · Cited by 63
Mechanistic systems modeling to guide drug discovery and development
Schmidt, B. J., Papin, J. A., & Musante, C. J. (2012) · Drug Discovery Today · doi:10.1016/j.drudis.2012.09.003 · Cited by 59
Metabolic network modeling and simulation for drug targeting and discovery
Kim, H. U., Sohn, S. B., & Lee, S. Y. (2011) · Biotechnology Journal · doi:10.1002/biot.201100159 · Cited by 59
English, S. B., & Butte, A. J. (2007) · Bioinformatics · doi:10.1093/bioinformatics/btm483 · Cited by 56
Traditional drug-discovery model ripe for reform
Cressey, D. (2011) · Nature · doi:10.1038/471017a · Cited by 54
Electronic health records: Implications for drug discovery
Yao, L., Zhang, Y., Li, Y., Sanséau, P., & Agarwal, P. (2011) · Drug Discovery Today · doi:10.1016/j.drudis.2011.05.009 · Cited by 54
Functional Analysis and Characterization of Differential Coexpression Networks
Hsu, C., Juan, H., & Huang, H. (2015) · Scientific Reports · doi:10.1038/srep13295 · Cited by 52
Chen, B. D., Greenside, P., Paik, H., Sirota, M., Hadley, D., & Butte, A. J. (2015) · CPT Pharmacometrics & Systems Pharmacology · doi:10.1002/psp4.12009 · Cited by 51
Two-stage flux balance analysis of metabolic networks for drug target identification
Li, Z., Wang, R., & Zhang, X. (2011) · BMC Systems Biology · doi:10.1186/1752-0509-5-s1-s11 · Cited by 51
EVALUATION OF ANALYTICAL METHODS FOR CONNECTIVITY MAP DATA
Cheng, J., Xie, Q. S., Kumar, V. D., Hurle, M. R., Freudenberg, J., Yang, L., & Agarwal, P. (2012) · Pacific Symposium on Biocomputing (PSB) · doi:10.1142/9789814447973_0002 · Cited by 51
Efficient discovery of responses of proteins to compounds using active learning
Kangas, J. D., Naik, A. W., & Murphy, R. F. (2014) · BMC Bioinformatics · doi:10.1186/1471-2105-15-143 · Cited by 48
Chavali, A. K., Blazier, A. S., Tlaxca, J. L., Jensen, P. A., Pearson, R. D., & Papin, J. A. (2012) · BMC Systems Biology · doi:10.1186/1752-0509-6-27 · Cited by 48
ProphNet: A generic prioritization method through propagation of information
Martínez, V., Cano, C., & Blanco, A. J. (2014) · BMC Bioinformatics · doi:10.1186/1471-2105-15-s1-s5 · Cited by 46
Orphan/rare drug discovery through drug repositioning
Muthyala, R. (2011) · Drug Discovery Today Therapeutic Strategies · doi:10.1016/j.ddstr.2011.10.003 · Cited by 45
Fan, S., Geng, Q., Pan, Z., Li, X., Tie, L., Pan, Y., & Li, X. (2012) · BMC Systems Biology · doi:10.1186/1752-0509-6-152 · Cited by 39
Probabilistic drug connectivity mapping
Parkkinen, J., & Samuel Kaski, A. (2014) · BMC Bioinformatics · doi:10.1186/1471-2105-15-113 · Cited by 38
Network medicine: linking disorders
Piro, R. M. (2012) · Human Genetics · doi:10.1007/s00439-012-1206-y · Cited by 36
Liu, M., Cai, R., Hu, Y. Q., Matheny, M. E., Sun, J., Hu, J. X., & Xu, H. (2013) · Journal of the American Medical Informatics Association · doi:10.1136/amiajnl-2013-002051 · Cited by 36
Genome-Scale Screening of Drug-Target Associations Relevant to Ki Using a Chemogenomics Approach
Cao, D., Liang, Y., Deng, Z., Hu, Q., He, M., Xu, Q., Zhou, G., Zhang, L., Deng, Z., & Liu, S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0057680 · Cited by 35
Exploring the relationship between drug side-effects and therapeutic indications.
Zhang, P., Wang, F., Hu, J., & Sorrentino, R. (2013) · Europe PMC (PubMed Central) · Cited by 34
McArt, D. G., & Zhang, S. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016382 · Cited by 34
Cheminformatics at the interface of medicinal chemistry and proteomics
Koch, U., Hamacher, M., & Nußbaumer, P. (2013) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2013.05.010 · Cited by 32
Targeting molecular networks for drug research
Pinto, J., Machado, R. S. R., Xavier, J. M., & Futschik, M. E. (2014) · Frontiers in Genetics · doi:10.3389/fgene.2014.00160 · Cited by 29
The BigChaos Solution to the Netflix Prize 2008
Töscher, A. (2008) · Cited by 27
Lee, J. A., Shinn, P., Jaken, S., Oliver, S. E., Willard, F. S., Heidler, S., Peery, R. B., Oler, J., Chu, S., Southall, N. T., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0130796 · Cited by 24
AN INTEGRATIVE PIPELINE FOR MULTI-MODAL DISCOVERY OF DISEASE RELATIONSHIPS
Glicksberg, B. S., Li, L., Cheng, W., Shameer, K., Hakenberg, J., Castellanos, R., Ma, M., Shi, L., Shah, H., Dudley, J. T., et al. (2014) · Pacific Symposium on Biocomputing (PSB) · doi:10.1142/9789814644730_0039 · Cited by 23
Self-citationLi, R., Dong, Y., Kuang, Q., et al. (2015) · Chemometrics and Intelligent Laboratory Systems · doi:10.1016/j.chemolab.2015.03.013 · Cited by 21
Similarity‐Based Modeling Applied to Signal Detection in Pharmacovigilance
Vilar, S., Ryan, P. O., Madigan, D., Stang, P., Schuemie, M. J., Friedman, C., Tatonetti, N. P., & Hripcsak, G. M. (2014) · CPT Pharmacometrics & Systems Pharmacology · doi:10.1038/psp.2014.35 · Cited by 21
Liu, Z., Borlak, J. T., & Tong, W. (2014) · Genome Medicine · doi:10.1186/s13073-014-0094-2 · Cited by 20
Integrative Genomics and Drug Development
Lum, P. Y., Derry, J. M. J., & Schadt, E. E. (2009) · Pharmacogenomics · doi:10.2217/14622416.10.2.203 · Cited by 18
Molineris, I., Ala, U., Provero, P., & Cunto, F. D. (2013) · BMC Bioinformatics · doi:10.1186/1471-2105-14-288 · Cited by 15
Ramachandran, S. S., Osterhaus, S. R., Karp, P. H., Welsh, M. J., & McCray, P. B. (2014) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2014-0007oc · Cited by 12
Saporito, M. S., Lipinski, C. A., & Reaume, A. G. (2012) · Wiley eBooks · doi:10.1002/9781118274408.ch9 · Cited by 8
Ben‐Dayan, M., MacCarthy, T., Schlecht, N. F., Belbin, T. J., Childs, G. J., Smith, R. V., Prystowsky, M. B., & Bergman, A. (2015) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2014-0624-oa · Cited by 7
Cited by
Modeling polypharmacy side effects with graph convolutional networks
Zitnik, M., Agrawal, M., & Leskovec, J. (2018) · Bioinformatics · doi:10.1093/bioinformatics/bty294 · Cited by 1,501
Zitnik, M., Nguyen, F., Wang, B., Leskovec, J., Goldenberg, A., & Hoffman, M. M. (2019) · Information Fusion · doi:10.1016/j.inffus.2018.09.012 · Cited by 675
Systematic integration of biomedical knowledge prioritizes drugs for repurposing
Himmelstein, D. S., Lizee, A., Hessler, C., Brueggeman, L., Chen, S. L., Hadley, D., Green, A., Khankhanian, P., & Baranzini, S. E. (2017) · eLife · doi:10.7554/elife.26726 · Cited by 666
Drug repurposing approach to fight COVID-19
Singh, T. U., Parida, S., Lingaraju, M. C., Kesavan, M., Kumar, D., & Singh, R. K. (2020) · Pharmacological Reports · doi:10.1007/s43440-020-00155-6 · Cited by 480
A systematic analysis of FDA-approved anticancer drugs
Sun, J., Wei, Q., Zhou, Y., Wang, J., Liu, Q., & Xu, H. (2017) · BMC Systems Biology · doi:10.1186/s12918-017-0464-7 · Cited by 322
Metadata
- Authors
- Hodos, R. A., Kidd, B. A., Shameer, K., Readhead, B. P., & Dudley, J. T.
- Venue
- WIREs Systems Biology and Medicine
- Publisher
- Wiley
- Published
- 2016-04-15
- Volume
- 8
- Issue
- 3
- Pages
- 186-210
- ISSN
- 1939-005X (ISSN-L)
- 1939-5094
- OpenAlex
- W2341574236
- Cited by
- 326
- References
- 153
- FWCI
- 27.09
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.